Biotricity
OTC: BTCYRedwood City, US · Founded 2012 · Nevada corporation
Find your way into Biotricity
618 people in our graph share verified history with the Biotricity team — schools, employers, funds. One of them is your warm intro.
Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
Founders & leadership
Biotricity was founded in 2012 by Waqaas Al-Siddiq and Dr. Waqaas Alsiddiq, DBA.

Reported raises · per SEC filings
Form D private placements$10.6M disclosed across 5 rounds · 2016–2024
▶$1MraisedApr 2024 · 1 investors · BiotechnologyRule 506(b)
- Chester WhiteDirector
- David A. RosaDirector
- John AyanoglouExecutive Officer
- Waqaas Al-SiddiqExecutive Officer, Director
- Ronald McClurgDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1M
- First sale
- Mar 2024
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.3MraisedAug 2020 · 24 investors · BiotechnologyRule 506(b)
- David RosaDirector
- Steve SalmonDirector
- Patricia KennedyDirector
- Waqaas Al-SiddiqExecutive Officer, Director
- John AyanoglouExecutive Officer
- Norman BettsDirector
- Offering amount
- $10M
- Amount sold
- $1.3M
- Minimum investment
- $100K
- Sales commissions
- $1.2M
- Placement agents
- Paulson Investment Company
- First sale
- Jul 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$6MraisedDec 2019 · 1 investors · BiotechnologyRule 506(b)
- Waqaas Al-SiddiqExecutive Officer, Director
- John AyanoglouExecutive Officer
- Offering amount
- $10M
- Amount sold
- $6M
- First sale
- Dec 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.2MraisedMar 2017 · BiotechnologyRule 506(b)
- Waqaas Al-SiddiqExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $1.2M
- Minimum investment
- $50K
- Sales commissions
- $100K
- Placement agents
- Corinthian Partners LLC
- First sale
- Mar 2017
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$1.1MraisedAug 2016 · 4 investors · Other Health CareRule 506(b)
- Waqaas Al-SiddiqExecutive Officer, Director
- Norman M. Betts, M.D.Director
- David A. RosaDirector
- Offering amount
- $2.5M
- Amount sold
- $1.1M
- First sale
- Mar 2016
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapCompanies competing with Biotricity for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Biotricity (BTCY) revenue rises as filing raises doubt on survivalstocktitan.net · Aug 2026Frequently asked questions
- What does Biotricity do?
- Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
- Who founded Biotricity?
- Biotricity was founded by Waqaas Al-Siddiq, Dr. Waqaas Alsiddiq, DBA in 2012.
- How much funding has Biotricity raised?
- Biotricity has disclosed $10.6M raised across 5 rounds.
- Where is Biotricity headquartered?
- Biotricity is headquartered in Redwood City, US.



